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Abstract
Plasmacytoid dendritic cells (pDC) produce type I interferons (IFN-I) and proinflammatory cytokines in response to viruses;
however, their contribution to antiviral immunity in vivo is unclear. In this study, we investigated the impact of pDC
depletion on local and systemic antiviral responses to herpes simplex virus (HSV) infections using CLEC4C-DTR transgenic
mice. We found that pDC do not appear to influence viral burden or survival after vaginal HSV-2 infection, nor do they seem
to contribute to virus-specific CD8 T cell responses following subcutaneous HSV-1 infection. In contrast, pDC were
important for early IFN-I production, proinflammatory cytokine production, NK cell activation and CD8 T cell responses
during systemic HSV-2 and HSV-1 infections. Our data also indicate that unlike pDC, TLR3-expressing cells are important for
promoting antiviral responses to HSV-1 regardless of the route of virus administration.
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Introduction
Most cells are able to produce type I interferons (IFN-I) in response
to viruses, however, some cell types such as plasmacytoid dendritic
cells (pDC) are more efficient than others. pDC detect RNA and DNA
viruses through two endosomal sensors, Toll-like receptor (TLR) 7 and
TLR9, respectively, which induce secretion of IFN-I through the
MyD88-IRF7 signaling pathway [1–3]. Because of their capacity to
produce IFN-I, as well as proinflammatory cytokines, and their ability
to present antigens to T cells, pDC are thought to be important for
promoting immune responses, particularly to viruses [4,5].
In order to evaluate the contribution of pDC to innate and
adaptive antiviral responses in vivo, depletion studies are
warranted. Several mouse models to eliminate pDC have been
described. First attempts used antibody (Ab)-mediated depletion of
pDC [6]. Within the past few years, genetically modified mouse
strains have become available that lack pDC either constitutively
[7,8] or by inducible depletion [9,10]. CLEC4C-DTR transgenic
(Tg) mice have been generated that express the diphtheria toxin
receptor (DTR) under the control of the CLEC4C promoter [9].
CLEC4C, also known as blood dendritic cell antigen 2, is a type II
C type lectin that is uniquely expressed by human pDC [11,12].
Injection of diphtheria toxin (DT) into CLEC4C-DTR Tg mice
selectively eliminates pDC [9]. Recently, a SiglecH-DTR knockin
mouse was described that has an IRES-DTR-EGFP cassette
inserted into the SiglecH locus [10]. These mice not only lack
SiglecH expression, but can also be depleted of pDC after DT
administration. SiglecH is a member of the sialic acid-binding
immunoglobulin (Ig)-like lectin family that is routinely used to
discriminate pDC from other cell types in mice [13,14].
Herpes simplex virus (HSV)-1 and HSV-2 are large double-
stranded DNA viruses that infect epithelial or epidermal cells before
establishing a latent infection in sensory neurons [15]. Both innate
and adaptive immune responses are necessary for limiting viral
replication and maintaining latency [16]. pDC detect HSV and
produce IFN-I and proinflammatory cytokines via TLR9 [17–20].
Ab-mediated depletion studies have suggested a critical role for
pDC in promoting immunity to HSV both locally and systemically.
Because the available pDC-depleting Abs also cross-react with other
cell types, we decided to investigate the impact of pDC depletion on
local and systemic antiviral responses to HSV infections using
CLEC4C-DTR Tg mice. We found that the absence of pDC did
not appear to influence antiviral responses to local HSV-2 and
HSV-1 infections. In contrast, pDC were important for IFN-I
production, NK cell activation and CD8 T cell responses following
systemic HSV-2 and HSV-1 infections. Our findings suggest that
previous studies highlighting a protective role for pDC during local
HSV infections may be related to the depletion of other cell types.
Our data also corroborate previously published findings that TLR3-
expressing cells, unlike pDC, are critical for antiviral CD8 T cell
responses to HSV-1 regardless of the route of administration [21]
and are a major source of IFN-I during systemic infection that
promotes NK cell activation at later time points post-infection (p.i.).
Altogether, our study demonstrates that the cellular sources of IFN-I
and antigen-presenting cells that mediate antiviral responses to
HSV infections vary depending on the route of infection.
Results
Limited impact of pDC on viral burden, local IFN-I and
survival during vaginal HSV-2 infection
It has been reported that in humans pDC infiltrate the dermis of
recurrent genital herpes simplex lesions and are closely associated
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with T cells and NK cells and thus, may contribute to control of
recurrent herpes virus infection in vivo [22]. pDC have also been
detected in the vaginal mucosa of mice infected with HSV-2
[23,24]. Ab-mediated depletion of pDC using 120G8 [25] or
mPDCA1 [26] during vaginal HSV-2 infection impairs innate
antiviral responses [23]. pDC-depleted mice showed higher viral
titers on days 2 and 3 p.i., reduced IFN-I responses and survival
following HSV-2 challenge [23]. Since the available antibodies to
deplete pDC, which include 120G8 [25], mPDCA1 [26], 927
[27] and Gr-1 [28,29], also react with other cell types we decided
to evaluate the involvement of pDC in vaginal HSV-2 infection
using genetically modified mice where pDC are selectively
eliminated after DT administration [9]. To this end, CLEC4C-
DTR Tg mice were injected with phosphate buffered saline (PBS)
or DT then infected intravaginally (ivag) with HSV-2. We found
that pDC in the lumbar lymph nodes, which drain the vagina,
were efficiently depleted at the time of infection (Figure 1A).
Depletion of pDC did not impact viral burden or IFN-a in
vaginal tissues on day 2 p.i. (Figure 1B and 1C). We next
determined whether pDC ablation impaired survival to HSV-2
infection. Mice were depleted of pDC or not and challenged with
two different doses of HSV-2 ivag (Figure 1D). Survival was
monitored for 15 days. Both groups of mice infected with
16104 pfu of virus had a survival rate of approximately 20% by
day 15. When a lower dose of virus was administered
(26103 pfu), around 50% of control and pDC-depleted mice
succumbed to infection by day 15. These results suggest that pDC
do not strongly influence viral burden or survival following
vaginal HSV-2 infection and that previous findings describing a
major role for pDC in antiviral responses to HSV-2 may be
related to the depletion of other cell types that are critical for
controlling vaginal HSV-2 infection.
pDC do not contribute to antiviral CD8 T cell responses
following subcutaneous HSV-1 infection
It has also been described, using Ab-mediated ablation, that
pDC are imperative for optimal HSV-1-specific CD8 T cell
responses after cutaneous infection [30]. In this study, pDC
depletion impaired DC functions and cytotoxic T cell-mediated
virus eradication in draining lymph nodes (DLN) [30]. Given that
Ab administration may potentially deplete non-pDC in this model
as well, we decided to evaluate local anti-HSV-1 CD8 T cell
responses in CLEC4C-DTR Tg mice depleted or not of pDC.
First, we confirmed that pDC are efficiently depleted in the
popliteal lymph nodes of DT-treated mice (Figure 2A). We then
infected control and depleted mice with HSV-1 in the footpad. On
day 7 p.i. we measured total numbers of pDC, CD8 and CD4 T
cells in DLN; the ability of cells from DLN to lyse target cells
pulsed with HSV gB peptide; frequencies of gB-specific CD8 T
cells in DLN and spleen; and viral burden in DLN (Figure 2 and
data not shown). Our results show that pDC were largely reduced
in the DLN of DT-treated mice on day 7 p.i. suggesting their
absence throughout the course of infection (Figure 2B) and that
absolute numbers of CD8 and CD4 T cells in DLN were
comparable between PBS and DT-treated mice (Figure 2C). We
also found using standard chromium release assays that cells from
DLN of PBS and DT-treated mice were equally capable of lysing
peptide-pulsed target cells (Figure 2D). Furthermore, when cells
from DLN and spleen were restimulated with HSV gB peptide
both PBS and DT-treated mice had approximately 2% of total
Figure 1. Impact of pDC on vaginal HSV-2 infection. CLEC4C-DTR
Tg mice were injected subcutaneously with Depo-Provera or medrox-
yprogesterone acetate 7 days before vaginal HSV-2 infection. Mice were
injected i.p. with PBS or DT 24 h before infection and every other day
after. (A) Dotplots show pDC frequencies in lumbar lymph nodes of PBS
or DT-treated mice at the time of infection. HSV-2 titers (B) and IFN-a
levels (C) in vaginal/cervical tissues on day 2 p.i. after inoculation with
16103 pfu. (D) Control or pDC-depleted mice were infected with 26103
or 16104 pfu of HSV-2 and survival was monitored for 15 days. Data are




Herpes simplex viruses (HSV) cause a variety of diseases in
human from the common cold sore to more severe
illnesses such as pneumonia, herpes simplex keratitis,
genital herpes and encephalitis. HSV are large double-
stranded DNA viruses that infect epithelial or epidermal
cells before establishing a latent infection in sensory
neurons. Both innate and adaptive immune responses are
necessary for limiting viral replication and maintaining
latency. Viral detection through distinct pathogen recog-
nition pathways triggers several signaling cascades that
lead to the production of proinflammatory cytokines and
type I interferons, which establish inflammation, confer an
antiviral state and promote immune responses. Our study
provides new insights into the cell types and pathogen
recognition pathways involved in antiviral defense to HSV
at local and systemic barriers and thus, might facilitate the
development of novel strategies to treat HSV infections.
pDC Responses to HSV Infections
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CD8 T cells in DLN and 12% of total CD8 T cells in spleen that
produced IFN-c by intracellular staining (Figure 2E and 2F).
Finally, we attempted to measure viral burden in DLN by plaque
assay on day 7 p.i. but were not able to detect HSV-1 in either
PBS or DT-treated mice (data not shown). This is in contrast to
the study by Yoneyama et al. which detected HSV-1 in DLN on
day 7 p.i. in pDC-depleted mice [30]. Taken together these data
suggest that the contribution of pDC to antiviral CD8 T cell
responses during local HSV-1 infection is negligible in the
CLEC4C-DTR Tg mouse model.
pDC produce cytokines and promote NK cell activation in
response to systemic HSV-2 infection
Previous studies using either Ab-mediated depletion of pDC or
SiglecH-DTR knockin mice injected with DT to eliminate pDC
have demonstrated a major role for pDC in innate and/or
adaptive responses to systemic HSV-2 or HSV-1 infections
[10,31,32]. Depletion of pDC with Ab in mice infected
systemically with HSV-2 results in reduced serum IFN-I levels,
augmented IL-17 production and higher viral burden in liver
Figure 2. Contribution of pDC to virus-specific CD8 T cell responses after local HSV-1 infection. Control (PBS) and pDC-depleted (DT)
mice were infected in the footpad with HSV-1. Draining popliteal lymph nodes (DLN) and spleens were analyzed on day 7 p.i. (A) Dotplots show pDC
frequencies in popliteal lymph nodes of PBS or DT-treated mice at the time of infection. (B) pDC numbers in DLN of PBS or DT-treated mice on day
7 p.i. (C) Total numbers of CD8 and CD4 T cells in DLN. (D) Antigen-specific lysis using DLN cells as effectors and HSV gB peptide-pulsed or unpulsed
EL4 cells as targets was assessed in standard 4 h 51Cr release assays. (E, F) Frequencies of CD8 T cells producing IFN-c in DLN and spleens after
restimulation with HSV gB peptide. Data are combined from or are representative of two independent experiments.
doi:10.1371/journal.ppat.1003728.g002
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[31,32]. In the case of HSV-1, SiglecH-DTR knockin mice depleted
of pDC have impaired systemic IFN-a levels and virus-specific CD8
T cell responses [10]. Therefore, we next decided to investigate
whether pDC depletion in our mouse model impacted antiviral
responses to systemic HSV infections. To this end, we injected
CLEC4C-DTR Tg mice with PBS or DT then infected mice
intravenously (i.v.) with either HSV-2 (Figure 3) or HSV-1 (Figure 4).
In the absence of pDC, there was a dramatic reduction in serum IFN-
a and IFN-c levels 8 h after systemic HSV-2 infection (Figure 3A).
IL-12p70 levels also appeared to be reduced in pDC-depleted mice
but numbers did not reach statistical significance (Figure 3A). Serum
IFN-a levels were still decreased in pDC-depleted mice at 12 h p.i.
(Figure 3B) and NK cell activation, as measured by intracellular IFN-
c and CD107a staining, was impaired in the absence of pDC
(Figure 3C–3E). However, in contrast to the study by Stout-Delgado
et al. [32], serum IL-17 levels were undetectable in our PBS or DT-
treated mice (data not shown). Finally, we performed a dose response
experiment to determine whether pDC-depleted mice were more
susceptible to systemic HSV-2 infection (Figure 3F). Mice were
injected with PBS or DT and infected with different doses of HSV-2
i.v. At a dose of 16107, mice in both groups died on days 4 and 5,
while at the lowest dose (16103) all mice survived. Infection with
16105 pfu per mouse revealed a strong difference in survival between
control and pDC-depleted mice (80% versus 20%). Taken together,
these data indicate that pDC promote antiviral responses and play a
protective role during systemic HSV-2 infection.
pDC are critical for optimal antiviral responses to
systemic HSV-1 infection
Similar to our findings with systemic HSV-2 infection,
CLEC4C-DTR Tg mice depleted of pDC had impaired antiviral
Figure 3. pDC produce IFN-I and activate NK cells during systemic HSV-2 infection. CLEC4C-DTR Tg mice were depleted (DT) or not (PBS)
of pDC then infected i.v. with HSV-2 (56106 pfu). (A) Serum IFN-a, IFN-c and IL-12p70 levels were measured 8 h p.i. (B) Serum IFN-a levels at 12 h p.i.
in control and pDC-depleted mice. Frequencies of IFN-c-producing NK cells (NK1.1+CD32) (C, D) and CD107a+ NK cells (E) in spleens were determined
12 h p.i. (F) PBS and DT-treated mice were infected i.v. with different doses of HSV-2. Survival was monitored for 15 days. Data are representative of
two independent experiments. Statistical significance is indicated by p values. Not significant (NS).
doi:10.1371/journal.ppat.1003728.g003
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responses to systemic HSV-1 (Figure 4). Analyses of serum IFN-a
(Figure 4A) and IFN-c (Figure 4B) levels revealed that pDC-
depleted mice had lower amounts of both cytokines compared to
PBS-treated mice at 6 h p.i. Although pDC-depleted mice had ,3
fold less serum IFN-c at 12 h p.i. (Figure 4B), they had a modest
reduction in levels of IFN-a (Figure 4A) compared to control mice,
suggesting that other cell types and/or viral sensors are involved in
sensing systemic HSV-1 infection and producing IFN-I. Exami-
nation of spleens from HSV-1-infected mice at 12 h p.i. revealed
that NK cells from pDC-depleted mice expressed lower levels of
CD69 (Figure 4C). Additionally, spleens from DT-treated mice
had lower frequencies of CD107a+ and IFN-c-producing NK cells
compared to PBS-treated mice (Figure 4D–4F). We also evaluated
whether CD4 T cells and NKT cells produced IFN-c in infected
control and pDC-depleted mice (data not shown and Figure 4G).
Although we did not detect IFN-c production by CD4 T cells at
this time point, we did observe similar frequencies of IFN-c-
producing NKT cells from PBS and DT-treated mice.
On day 7 p.i. we measured virus-specific CD8 T cell responses
in spleens by intracellular IFN-c staining after restimulation with
HSV gB peptide (Figure 4H). pDC-depleted mice showed a 25–
30% reduction in IFN-c-producing CD8 T cells compared to
PBS-treated mice. We have previously shown that pDC do not
prime virus-specific CD8 T cells but appear to promote their
survival during vesicular stomatitis virus infection [9]. To
determine how pDC impact virus-specific CD8 T cells during
systemic HSV-1 infection we injected CFSE-labeled CD8 T cells
from gBT-I Tg mice [33] into CLEC4C-DTR Tg mice. Following
administration of PBS or DT and infection with HSV-1 we
measured accumulation and proliferation of gB-specific CD8 T
cells in spleens on day 3 p.i. (Figure 4I). Transferred T cells
accumulated in control and pDC-depleted mice and exhibited
similar levels of CFSE dilution and CD25, suggesting that the
absence of pDC may alter the functional ability of virus-specific
CD8 T cells to produce IFN-c rather than their proliferation or
accumulation.
Although our IFN-I and CD8 T cell results during systemic
HSV-1 infection are similar to those obtained using pDC-depleted
SiglecH-DTR knockin mice [10], we were not able to detect viral
replication in spleens of either PBS or DT-treated CLEC4C-DTR
Tg mice on day 7 p.i. (data not shown) in contrast to the Takagi et
al. study. This discrepancy may reflect differences in the strains of
HSV-1 used (KOS versus strain F) or differences in the promoter
used to drive DTR expression (CLEC4C versus SiglecH). It has
been shown that SiglecH is expressed by specialized macrophage
subsets and progenitors of pDC and classical DC [14,34,35].
Thus, it is possible that certain SiglecH+ subsets other than pDC
Figure 4. pDC promote antiviral responses during systemic
HSV-1 infection. Control (PBS) and pDC-depleted (DT) mice were
infected i.v. with HSV-1 (16107 pfu). Serum IFN-a (A) and IFN-c (B) were
measured at 6 and 12 h p.i. (C) CD69 expression on NK cells
(NK1.1+CD32) from spleens of PBS or DT-treated mice 12 h p.i.
Frequencies of CD107a+ (D) and IFN-c-producing NK cells (E, F) in
spleens of HSV-1 infected mice 12 h p.i. (G) Frequencies of IFN-c-
producing NKT cells (NK1.1+CD3+) in spleens of HSV-1 infected mice
12 h p.i. (H) Frequencies of IFN-c-producing CD8 T cells in spleens on
day 7 p.i. after restimulation with HSV gB peptide. (I) CFSE-labeled CD8
T cells from gBT-I mice were injected i.v. into CLEC4C-DTR Tg mice. Mice
were depleted or not of pDC and infected i.v. with HSV-1 (16107 pfu).
Spleens were analyzed on day 3 p.i. for numbers of transferred CD8 T
cells, CFSE dilution and CD25 levels. Dotplots and histograms are
representative of four mice per group. Data are representative of one (I)
or two-three independent experiments (A–H). Statistical significance is
indicated by p values. Not significant (NS).
doi:10.1371/journal.ppat.1003728.g004
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are functionally altered and/or depleted in SiglecH-DTR knockin
mice thus yielding stronger phenotypes (i.e. major reductions in
IFN-I and/or CD8 T cell responses and increased viral
replication) than what we observe in CLEC4C-DTR Tg mice.
TLR3-expressing cells contribute to antiviral responses
after systemic and local HSV-1 infections
Although we detected reduced IFN-a responses in pDC-
depleted mice 6 h post-HSV-1 infection, at 12 h p.i. there were
modest differences in IFN-a levels between control and pDC-
depleted mice (Figure 4A). These data indicate that pDC are not
the only source of IFN-a during systemic HSV-1 infection and
prompted us to examine which sensor was responsible for IFN-a
production in the presence or absence of pDC at later time points.
TLR3 has a prominent role in HSV-1 recognition and IFN-I
production [36–38]. In human, TLR3 has proven essential for the
recognition of HSV-1 in the brain most likely though the
generation of RNA intermediates that occur during viral
replication that gain access to the endosomal compartment by
phagocytosis or endocytosis [36–39]. Thus, we infected wildtype
(WT) and TLR32/2 mice i.v. with HSV-1 and measured serum
IFN-a levels at 6 and 12 h p.i. We found that at 6 h p.i. TLR3-
deficiency did not impact IFN-a levels; however, at 12 h p.i. IFN-
a production was greatly diminished in TLR32/2 mice
(Figure 5A). These data indicate that pDC are important for the
early burst of IFN-a during HSV-1 infection while TLR3 signaling
is essential for the later burst of IFN-a.
We also found that serum IFN-c levels were decreased in
TLR32/2 mice at 6 and 12 h p.i. (Figure 5B), suggesting a defect
in NK cell activation. Examination of spleens at 12 h p.i. revealed
that NK cells from TLR32/2 mice expressed lower levels of CD69
(Figure 5C). Moreover, spleens from TLR32/2 mice had reduced
numbers of CD107a+ and IFN-c-producing NK cells compared to
infected WT mice (Figure 5D–5F). We also looked at IFN-c
production by CD4 T cells and NKT cells in WT and TLR32/2
mice 12 h p.i. and observed a reduction in activated NKT cells but
not CD4 T cells (Figure 5G and data not shown). Prior work has
demonstrated that in mice TLR3 expression and CD8a DC,
which express high levels of TLR3, are important for virus-specific
CD8 T responses following subcutaneous, intravenous and flank
HSV-1 infections [21,40]. To this end, we infected WT and
TLR32/2 mice i.v. with HSV-1 and measured virus-specific CD8
T cells in spleens on day 7 p.i. by intracellular IFN-c staining after
restimulation with HSV gB peptide (Figure 5H). TLR32/2 mice
showed a ,50% reduction in IFN-c-producing CD8 T cells
compared to WT mice. Next, we measured serum IFN-a levels
and CD8 T cell responses in Batf32/2 mice, which have a defect
in CD8a DC numbers [41,42], after systemic HSV-1 infection.
Interestingly, Batf32/2 mice produced lower levels of IFN-a
compared to WT mice 12 h p.i., which were similar to those
observed in TLR32/2 mice (Figure 5I). Analyses of spleens on day
7 p.i. revealed that Batf32/2 mice had fewer numbers of total
CD8 T cells (Figure 5J) and had reduced frequencies and numbers
of IFN-c-producing CD8 T cells after restimulation with HSV gB
peptide (Figure 5K and 5L). Thus, we conclude that while pDC
contribute modestly to late IFN-a production and CD8 T cell
responses during systemic HSV-1 infection, TLR3-expressing
cells, most likely CD8a DC, are required for late IFN-a
production and efficient priming and/or expansion of virus-
specific CD8 T cells [21,40,42].
Finally, to confirm that TLR3 expression is critical for antiviral
responses to HSV-1 regardless of the route of infection we
examined T cell numbers and responses in DLN of TLR32/2
mice following footpad infection. DLN from TLR32/2 mice
contained fewer numbers of total CD4 and CD8 T cells (Figure 6A
and 6B) as well as reduced numbers of IFN-c-producing CD8 T
cells after restimulation with HSV gB peptide (Figure 6C). Taken
together, these data corroborate previous findings and illustrate the
importance of TLR3 expression in antiviral responses to HSV-1.
Discussion
In this study, we evaluated antiviral responses during local and
systemic HSV infections in the presence and absence of pDC using
CLEC4C-DTR Tg mice. We found that pDC have a negligible
impact on viral burden, local IFN-I production and survival
during vaginal HSV-2 infection and virus-specific CD8 T cell
responses after subcutaneous HSV-1 infection. In contrast, pDC
were essential for optimal IFN-I production, NK cell activation,
CD8 T cell responses and survival following systemic HSV-2 and
HSV-1 infections. These findings suggest that the contribution of
pDC to antiviral immunity is dependent on the route of virus
entry. Although pDC are often recruited to sites of infection and
inflammation [43,44], in homeostatic conditions they are mainly
found in circulation and lymphoid tissues, which may explain why
they have a more prominent role in controlling systemic viral
infections. Indeed, it has been reported that following local
infections with viruses such as Newcastle disease virus and
vesicular stomatitis virus, macrophages are major sources of
IFN-I and promote antiviral responses [45,46].
Previous studies concluding a major role for pDC in controlling
local viral infections, such as HSV, may have been a consequence
of depleting other cell types in addition to pDC. This is a likely
scenario given that the currently available antibodies to deplete
pDC cross-react with other cell types. In early studies, pDC were
depleted with a monoclonal antibody (mAb) specific for the
antigen Gr-1 [28,29], which is shared by Ly6C and Ly6G. Ly6C is
expressed on pDC, but also on plasma cells, activated T cells and
inflammatory monocytes while Ly6G is expressed on granulocytes
[47–49]. Several other pDC-depleting mAbs have been developed,
including 120G8, mPDCA1 and 927 [25–27]. These mAbs
recognize bone marrow stromal cell Ag 2 (BST2). Although BST2
is selectively expressed on mouse pDC in naı¨ve mice, it is also
expressed by plasma cells and is upregulated on most cell types,
including classical DC, B cells, T cells, myeloid cells, NKT cells
and stromal cells following viral infections or stimulation with IFNs
[27]. Therefore, it is important to corroborate these conclusions in
mice that specifically lack pDC either transiently [9,10], consti-
tutively [7,8] or in mice that have a functional defect of pDC
[50,51].
In contrast to pDC-deficient mice, TLR32/2 mice display
impaired antiviral responses to HSV-1 regardless of the route of
virus entry. It has previously been reported that TLR3 is required
for the generation of CD8 T cell immunity to HSV-1 after flank
infection [21] and our results indicate that TLR32/2 mice have
reduced virus-specific CD8 T cell responses after systemic and
footpad infections. CD8a DC, which express high levels of TLR3,
are essential for inducing T cell-mediated immunity to HSV
following subcutaneous and systemic infections [40,42]. The
significance of TLR3 in sensing HSV has been corroborated by
studies showing that TLR3 deficiency in humans is associated with
increased susceptibility to herpes simplex encephalitis, although
this is mainly due to impairment of local responses rather than a
defect a CD8 T cell responses [36–38].
The importance of IFN-I in controlling systemic HSV-1
infections has been confirmed in mice lacking IRF7 and STING,
which have major defects in IFN-I responses [52,53]. Our data
and others [19] suggest that although pDC contribute to IFN-I
pDC Responses to HSV Infections
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Figure 5. TLR3-expressing cells are necessary for robust antiviral responses during systemic HSV-1 infection. (A–H) WT and TLR32/2
mice were infected i.v. with HSV-1 (16107 pfu). Serum IFN-a (A) and IFN-c (B) were measured at 6 and 12 h p.i. (C) CD69 expression on NK cells
(NK1.1+CD32) from spleens of WT and TLR32/2 mice 12 h p.i. Frequencies of CD107a+ (D) and IFN-c-producing NK cells (E, F) in spleens of HSV-1
infected mice 12 h p.i. (G) Frequencies of IFN-c-producing NKT cells (NK1.1+CD3+) in spleens of HSV-1 infected mice 12 h p.i. (H) Frequencies of IFN-c-
producing CD8 T cells in spleens on day 7 p.i. after restimulation with HSV gB peptide. (I) WT, TLR32/2 and Batf32/2mice were infected i.v. with HSV-
1 (16107 pfu). Serum IFN-a levels were measured 12 h p.i. (J–L) WT and Batf32/2 mice were infected i.v. with HSV-1 (16107 pfu). (J) Total CD8 T cells
in spleens on day 7 p.i. Frequencies (K) and numbers (L) of IFN-c-producing CD8 T cells in spleens on day 7 p.i. after restimulation with HSV gB
peptide. Data are representative of two or three independent experiments. Statistical significance is indicated by p values. Not significant (NS).
doi:10.1371/journal.ppat.1003728.g005
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production during systemic HSV-1, they are not the only source.
While pDC are mainly important for early IFN-I secretion, TLR3-
expressing cells, such as CD8a DC, are essential for IFN-I
production at later time points. Other TLR3-expressing cells that
might contribute to IFN-I during HSV-1 infection may include
both hematopoietic and non-hematopoietic cells such as marginal
zone macrophages, fibroblasts and stromal cells [36–38,54].
Taken together, our study indicates that some cell types are more
important than others for establishing antiviral immunity to a
given virus and that cell types expressing different viral sensors




For mouse studies at Washington University, the principles of
good laboratory animal care were carried out in strict accordance
with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
following the International Guiding Principles for Biomedical
Research Involving Animals. The protocols were approved by the
Animal Studies Committee at Washington University
(#20100280).
Mice and treatments
C57BL/6, CLEC4C-DTR Tg and TLR32/2 mice were bred
in house. Batf32/2 mice were kindly provided by K. Murphy and
W. KC (Washington University School of Medicine, St. Louis,
MO). All mice were on a C57BL/6 background and used at 6–12
weeks of age. Diphtheria toxin (DT, Sigma-Aldrich) was injected
i.p. into CLEC4C-DTR Tg mice (100–120 ng/mouse) 24 h prior
to infection and every other day after. Seven days prior to vaginal
infections, female CLEC4C-DTR Tg mice were injected subcu-
taneously with 2 mg of Depo-Provera or medroxyprogesterone
acetate in PBS as previously described [55].
Infections
HSV-1 KOS strain, provided by D. Leib (Dartmouth College,
Hanover, NH), was injected i.v. at 16107 pfu or in the footpad at
16105 pfu. HSV-2 strain 186TKDkpn was provided by A. Iwasaki
(Yale University, New Haven, CT). Mice were infected with
56106 pfu i.v. or 16103 pfu ivag of HSV-2. For susceptibility
studies, mice were infected with different doses of HSV-2 either
i.v. or ivag (specified in figures/legends).
Viral titers
Vaginal washes and vaginas and cervix from HSV-2-infected
mice were removed on day 2 p.i. weighed and stored at 280uC in
1 ml of plain DMEM. Spleens and DLN from HSV-1-infected
mice were removed on day 7 p.i. and stored at 280uC in 1 ml of
plain DMEM. On the day of titering, samples were thawed in a
37uC water bath then homogenized with a Roche MagNA Lyser.
Samples were centrifuged for 5 min at 5000 rpm then homoge-
nates were serially diluted in plain DMEM. Dilutions were applied
Figure 6. TLR3-expressing cells promote CD8 T cell responses
to local HSV-1 infection. WT and TLR32/2 mice were infected in the
footpad with HSV-1 (16105 pfu). Total CD4 (A) and CD8 (B) T cells were
analyzed in DLN on day 7 p.i. (C) Numbers of IFN-c-producing CD8 T
cells in DLN on day 7 p.i. after restimulation with HSV gB peptide. Data
are combined from two independent experiments. Statistical signifi-
cance is indicated by p values.
doi:10.1371/journal.ppat.1003728.g006
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to Vero cell monolayers in 12 well plates for 1 h at 37uC. After the
incubation period, an overlay containing complete DMEM and
1% methylcellulose was added and plates were incubated for 2–3
days. A second overlay with neutral red was applied 8 h before
counting plaques.
Cell preparations
Spleens and lymph nodes were minced and digested for 45 min
at 37uC in RPMI 1640 with collagenase D (Sigma-Aldrich). Single
cell suspensions were prepared by passage through nylon mesh cell
strainers (BD Biosciences). Red blood cells were lysed with RBC
lysis buffer (Sigma-Aldrich). Serum was separated from whole
blood in serum collection tubes and stored at220uC until analysis.
Adoptive transfers
CD8 T cells from gBT-I Tg mice [33] were isolated by negative
selection using the CD8a+ T cell Isolation Kit II according to the
manufacturer instructions (Miltenyi Biotec). Cells were labeled
with 5 mM CFSE and injected i.v. into CLEC4C-DTR Tg mice at
16106 cells per mouse. One day after transfer, mice were injected
with PBS or DT. One day later, mice were infected with
16107 pfu HSV-1 i.v. Spleens were analyzed for CD8+CFSE+ T
cells on day 3 p.i.
Cell lines and tissue culture
EL4 cells were grown in complete RPMI: RPMI 1640 (Gibco/
Invitrogen) with 10% bovine calf serum (BCS), 1% glutamax, 1%
nonessential amino acids, 1% sodium pyruvate and 1% kanamycin
sulfate (Gibco/Invitrogen). Vero cells were grown in DMEM with
10% BCS, 1% glutamax, 1% hepes and 1% pen/strep (Gibco/
Invitrogen). Primary cells were cultured in complete RPMI with
10% fetal calf serum (FCS, Hyclone).
Antibodies and flow cytometry
The following reagents were from BD Biosciences, eBioscience
or Biolegend. Fluorochrome labeled anti-CD3 (145-2C11), anti-
NK1.1 (PK136), anti-CD8a (53–6.7), anti-CD4 (MZ3), anti-IFN-c
(XMG1.2), CD69 (H1.2F3), CD107a (1D4B), CD25 (PC61), and
Streptavidin. Fc receptors were blocked before surface staining
with supernatant from HB-197 cells (ATCC). Propidium iodide
was used to gate out dead cells. CD107a staining on NK cells was
performed as previously described [56]. Briefly, splenocytes from
control and infected mice were cultured for 1 h with FITC-
conjugated CD107a. After the 1 h incubation, Brefeldin A and
monensin were added to wells for an additional 4 h. Cells were
stained with NK1.1. and CD3 then fixed with 2% paraformalde-
hyde. All flow cytometry was conducted on a dual laser
FACSCalibur flow cytometer (BD Biosciences) and analyzed with
FlowJo software (Tree Star, Inc.).
Intracellular staining
Spleen or lymph node cells from HSV-1-infected mice were
incubated in complete RPMI alone or with HSV gB peptide
(Anaspec, 10 mg/ml) in the presence of Brefeldin A. After 6 h, cells
were intracellularly stained for IFN-c using the Cytofix/Cytoperm
kit from BD Biosciences. IFN-c-producing NK and NKT cells
were also detected by intracellular staining using the Cytofix/
Cytoperm kit.
Cytotoxicity assays
For Ag-specific lysis assays, lymph nodes from HSV-1-infected
mice were resuspended in complete RPMI and serially diluted.
EL4 cells were pulsed or not with HSV gB peptide (10 ng/ml) and
labeled with 1 mCi/ml 51Cr for 2 h then incubated with effector
cells at 37uC for 4 h. 51Cr release in supernatants was measured
with a c-counter.
Cytokine analysis
Serum IFN-a and proinflammatory cytokine levels were
determined by ELISA (PBL Interferon Source) or Cytometric
Bead Array (BD Biosciences), respectively. For measurements of
IFN-a in tissue homogenates from HSV-2 infected mice, vaginas
and cervix were removed and weighed on day 2 p.i. then stored at
280uC in tubes with silica beads and lysis buffer: PBS, PMSF,
protease inhibitors, Triton X-100. Samples were thawed in a 37uC
water bath then homogenized with a Roche MagNA Lyser.
Samples were centrifuged for 5 min at 5000 rpm and supernatants
were diluted and used for ELISA.
Statistical analysis
The statistical significance of differences in mean values was
analyzed with unpaired, two-tailed Student’s t-test using Graph-
Pad Prism software. P values less than 0.05 were considered
statistically significant.
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